相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy of PARP Inhibition in Metastatic Castration-resistant Prostate Cancer is Very Different with Non-BRCA DNA Repair Alterations: Reconstructing Prespecified Endpoints for Cohort B from the Phase 3 PROfound Trial of Olaparib
Konrad H. Stopsack
EUROPEAN UROLOGY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent
Nicolas Mottet et al.
EUROPEAN UROLOGY (2021)
Homologous Recombination Deficiency Testing for BRCA-Like Tumors: The Road to Clinical Validation
Marjolijn M. Ladan et al.
CANCERS (2021)
Prostate cancer and PARP inhibitors: progress and challenges
Diego Teyssonneau et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Integrating PARP Inhibitors Into Advanced Prostate Cancer Therapeutics
Jun Gong et al.
ONCOLOGY-NEW YORK (2021)
The Role of PARP Inhibitors in the Treatment of Prostate Cancer: Recent Advances in Clinical Trials
Mingyue Xia et al.
BIOMOLECULES (2021)
Angiogenesis and Anti-Angiogenic Treatment in Prostate Cancer: Mechanisms of Action and Molecular Targets
Evangelia Ioannidou et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Genetic Aberrations of DNA Repair Pathways in Prostate Cancer: Translation to the Clinic
Aruni Ghose et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1) an-label, 2 trial
Johann S. de Bono et al.
LANCET ONCOLOGY (2021)
Role of the DNA damage response in prostate cancer formation, progression and treatment
Wenhao Zhang et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2020)
Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness
Vivek L. Patel et al.
CANCER RESEARCH (2020)
Structural basis of homologous recombination
Yueru Sun et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2020)
Veliparib in ovarian cancer: a new synthetically lethal therapeutic approach
Stergios Boussios et al.
INVESTIGATIONAL NEW DRUGS (2020)
Non-BRCA DNA Damage Repair Gene Alterations and Response to the PARP Inhibitor Rucaparib in Metastatic Castration-Resistant Prostate Cancer: Analysis From the Phase II TRITON2 Study
Wassim Abida et al.
CLINICAL CANCER RESEARCH (2020)
Phase III study of pembrolizumab (pembro) plus olaparib versus enzalutamide (enza) or abiraterone acetate (abi) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) who progressed on chemotherapy: KEYLYNK-010.
Evan Y. Yu et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial
Joaquin Mateo et al.
LANCET ONCOLOGY (2020)
Genetic Testing in Prostate Cancer
Alexandra O. Sokolova et al.
CURRENT ONCOLOGY REPORTS (2020)
Androgen receptor-binding sites are highly mutated in prostate cancer
Tunc Morova et al.
NATURE COMMUNICATIONS (2020)
The incidence of myelodysplastic syndrome in patients receiving poly-ADP ribose polymerase inhibitors for treatment of solid tumors: A meta-analysis.
Roni Nitecki et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Mismatch repair deficiency in metastatic prostate cancer: Response to PD-1 blockade and standard therapies
Laura S. Graham et al.
PLOS ONE (2020)
Poly (ADP-Ribose) Polymerase Inhibitors: Talazoparib in Ovarian Cancer and Beyond
Stergios Boussios et al.
DRUGS IN R&D (2020)
Olaparib for Metastatic Castration-Resistant Prostate Cancer
J. de Bono et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
C. Parker et al.
ANNALS OF ONCOLOGY (2020)
Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019
Veda N. Giri et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Mismatch Repair Pathway, Genome Stability and Cancer
Nives Pecina-Slaus et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2020)
An Update on the Prognostic and Predictive Serum Biomarkers in Metastatic Prostate Cancer
Helen Saxby et al.
DIAGNOSTICS (2020)
Wise Management of Ovarian Cancer: On the Cutting Edge
Stergios Boussios et al.
JOURNAL OF PERSONALIZED MEDICINE (2020)
Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a BRCA1 or BRCA2 Gene Alteration
Wassim Abida et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Advances in synthetic lethality for cancer therapy: cellular mechanism and clinical translation
Win Topatana et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
The involvement of nucleotide excision repair proteins in the removal of oxidative DNA damage
Namrata Kumar et al.
NUCLEIC ACIDS RESEARCH (2020)
Poly(ADP-Ribose) Polymerase Inhibitors in Prostate Cancer: Molecular Mechanisms, and Preclinical and Clinical Data
Dawid Sigorski et al.
TARGETED ONCOLOGY (2020)
PARP Inhibitors in Metastatic Prostate Cancer: Evidence to Date
Emily Nizialek et al.
CANCER MANAGEMENT AND RESEARCH (2020)
BRCA Mutations in Prostate Cancer: Prognostic and Predictive Implications
Carlo Messina et al.
JOURNAL OF ONCOLOGY (2020)
Development of new poly(ADP-ribose) polymerase (PARP) inhibitors in ovarian cancer: Quo Vadis?
Stergios Boussios et al.
ANNALS OF TRANSLATIONAL MEDICINE (2020)
DNA Damage Response in Prostate Cancer
Matthew J. Schiewer et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2019)
Bringing Prostate Cancer Germline Genetics into Clinical Practice
Sanjay Das et al.
JOURNAL OF UROLOGY (2019)
Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing Guidelines
Piper Nicolosi et al.
JAMA ONCOLOGY (2019)
Germline and Somatic Mutations in Prostate Cancer for the Clinician
Heather H. Cheng et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)
Selective Loss of PARG Restores PARylation and Counteracts PARP Inhibitor-Mediated Synthetic Lethality (vol 33, pg 1078, 2018)
Ewa Gogola et al.
CANCER CELL (2019)
PARP Inhibitors in Prostate Cancer-the Preclinical Rationale and Current Clinical Development
Verneri Virtanen et al.
GENES (2019)
PARP Inhibitors in Ovarian Cancer: The Route to Ithaca
Stergios Boussios et al.
DIAGNOSTICS (2019)
Combined Strategies with Poly (ADP-Ribose) Polymerase (PARP) Inhibitors for the Treatment of Ovarian Cancer: A Literature Review
Stergios Boussios et al.
DIAGNOSTICS (2019)
Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers
Elizabeth C. Page et al.
EUROPEAN UROLOGY (2019)
846PDPreliminary results from the TRITON2 study of rucaparib in patients (pts) with DNA damage repair (DDR)-deficient metastatic castration-resistant prostate cancer (mCRPC): Updated analyses
W Abida et al.
ANNALS OF ONCOLOGY (2019)
LBA50Pre-specified interim analysis of GALAHAD: A phase II study of niraparib in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) and biallelic DNA-repair gene defects (DRD)
M R Smith et al.
ANNALS OF ONCOLOGY (2019)
PARP Inhibitor Resistance: A Tug-of-War in BRCA-Mutated Cells
Sylvie M. Noordermeer et al.
TRENDS IN CELL BIOLOGY (2019)
PROREPAIR-B: A Prospective Cohort Study of the Impact of Germline DNA Repair Mutations on the Outcomes of Patients With Metastatic Castration-Resistant Prostate Cancer
Elena Castro et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Genomic Characterization of Prostatic Ductal Adenocarcinoma Identifies a High Prevalence of DNA Repair Gene Mutations
Michael T. Schweizer et al.
JCO PRECISION ONCOLOGY (2019)
ELL2 regulates DNA non-homologous end joining (NHEJ) repair in prostate cancer cells
Yachen Zang et al.
CANCER LETTERS (2018)
Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017
Veda N. Giri et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Intraductal/ductal histology and lymphovascular invasion are associated with germline DNA-repair gene mutations in prostate cancer
Pedro Isaacsson Velho et al.
PROSTATE (2018)
Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations
Fatima Karzai et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Mismatch repair system proteins in oral benign and malignant lesions
Gleyson Kleber do Amaral-Silva et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2017)
Overlapping roles for PARP1 and PARP2 in the recruitment of endogenous XRCC1 and PNKP into oxidized chromatin
Hana Hanzlikova et al.
NUCLEIC ACIDS RESEARCH (2017)
Mechanisms of DNA Damage, Repair, and Mutagenesis
Nimrat Chatterjee et al.
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2017)
DNA Repair in Prostate Cancer: Biology and Clinical Implications
Joaquin Mateo et al.
EUROPEAN UROLOGY (2017)
Coordination of DNA single strand break repair
Rachel Abbotts et al.
FREE RADICAL BIOLOGY AND MEDICINE (2017)
TOP BP1Dpb11 plays a conserved role in homologous recombination DNA repair through the coordinated recruitment of 53BP1Rad9
Yi Liu et al.
JOURNAL OF CELL BIOLOGY (2017)
Restoration of Replication Fork Stability in BRCA1-and BRCA2-Deficient Cells by Inactivation of SNF2-Family Fork Remodelers
Angelo Taglialatela et al.
MOLECULAR CELL (2017)
DNA mismatch repair and its many roles in eukaryotic cells
Dekang Liu et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2017)
EZH2 promotes degradation of stalled replication forks by recruiting MUS81 through histone H3 trimethylation
Beatrice Rondinelli et al.
NATURE CELL BIOLOGY (2017)
Androgen receptor inhibitor-induced BRCAness and PARP inhibition are synthetically lethal for castration-resistant prostate cancer
Likun Li et al.
SCIENCE SIGNALING (2017)
Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer
Mohammad Asim et al.
NATURE COMMUNICATIONS (2017)
DNA double-strand break repair pathway regulates PD-L1 expression in cancer cells
Hiro Sato et al.
NATURE COMMUNICATIONS (2017)
Androgen receptor inhibitor-induced BRCAness and PARP inhibition are synthetically lethal for castration-resistant prostate cancer
Likun Li et al.
SCIENCE SIGNALING (2017)
Diverse BRCA1 and BRCA2 Reversion Mutations in Circulating Cell-Free DNA of Therapy-Resistant Breast or Ovarian Cancer
Britta Weigelt et al.
CLINICAL CANCER RESEARCH (2017)
A Phase I-II Study of the Oral PARP Inhibitor Rucaparib in Patients with Germline BRCA1/2-Mutated Ovarian Carcinoma or Other Solid Tumors
Rebecca Kristeleit et al.
CLINICAL CANCER RESEARCH (2017)
PARP Inhibitors in Prostate Cancer
Praveen Ramakrishnan Geethakumari et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2017)
Endogenous DNA Damage as a Source of Genomic Instability in Cancer
Anthony Tubbs et al.
CELL (2017)
Prospective Genomic Profiling of Prostate Cancer Across Disease States Reveals Germline and Somatic Alterations That May Affect Clinical Decision Making
Wassim Abida et al.
JCO PRECISION ONCOLOGY (2017)
Human Cancers Express a Mutator Phenotype: Hypothesis, Origin, and Consequences
Lawrence A. Loeb
CANCER RESEARCH (2016)
DNA mismatch repair and the DNA damage response
Zhongdao Li et al.
DNA REPAIR (2016)
Mechanisms of Therapy Resistance in Patient-Derived Xenograft Models of BRCA1-Deficient Breast Cancer
Petra ter Brugge et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer
C. C. Pritchard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Mechanisms of Therapy Resistance in Patient-Derived Xenograft Models of BRCA1-Deficient Breast Cancer
Petra ter Brugge et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Integrative Clinical Genomics of Advanced Prostate Cancer
Dan Robinson et al.
CELL (2015)
The Molecular Taxonomy of Primary Prostate Cancer
Adam Abeshouse et al.
CELL (2015)
Genomic rearrangements in prostate cancer
Christopher E. Barbieri et al.
CURRENT OPINION IN UROLOGY (2015)
Effect of BRCA Mutations on Metastatic Relapse and Cause-specific Survival After Radical Treatment for Localised Prostate Cancer
Elena Castro et al.
EUROPEAN UROLOGY (2015)
Mismatch Repair
Richard Fishel
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
J. Mateo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Homologous Recombination and Human Health: The Roles of BRCA1, BRCA2, and Associated Proteins
Rohit Prakash et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2015)
Regulators of homologous recombination repair as novel targets for cancer treatment
Malgorzata Krajewska et al.
FRONTIERS IN GENETICS (2015)
BRCA2-Deficient Sarcomatoid Mammary Tumors Exhibit Multidrug Resistance
Janneke E. Jaspers et al.
CANCER RESEARCH (2015)
Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study
Elizabeth K. Bancroft et al.
EUROPEAN UROLOGY (2014)
Breathing new life into immunotherapy: review of melanoma, lung and kidney cancer
Charles G. Drake et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Understanding nucleotide excision repair and its roles in cancer and ageing
Jurgen A. Marteijn et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
MutS Homologues hMSH4 and hMSH5: Genetic Variations, Functions, and Implications in Human Diseases
Nicole Clark et al.
CURRENT GENOMICS (2013)
Secondary mutations in BRCA2 associated with clinical resistance to a PARP inhibitor
Louise J. Barber et al.
JOURNAL OF PATHOLOGY (2013)
Prediction of Clinical Drug-Drug Interactions of Veliparib (ABT-888) with Human Renal Transporters (OAT1, OAT3, OCT2, MATE1, and MATE2K)
Ryota Kikuchi et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Mammalian Base Excision Repair: the Forgotten Archangel
Grigory L. Dianov et al.
NUCLEIC ACIDS RESEARCH (2013)
Nucleotide Excision Repair in Eukaryotes
Orlando D. Schaerer
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
DNA Damage Sensing by the ATM and ATR Kinases
Alexandre Marechal et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
Base Excision Repair
Hans E. Krokan et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
Androgen Receptor Signaling Regulates DNA Repair in Prostate Cancers
William R. Polkinghorn et al.
CANCER DISCOVERY (2013)
The role of BRCA1 and BRCA2 in prostate cancer
Elena Castro et al.
ASIAN JOURNAL OF ANDROLOGY (2012)
ETS rearrangements in prostate cancer
Mark A. Rubin
ASIAN JOURNAL OF ANDROLOGY (2012)
Germline BRCA1 mutations increase prostate cancer risk
D. Leongamornlert et al.
BRITISH JOURNAL OF CANCER (2012)
A Distinct Replication Fork Protection Pathway Connects Fanconi Anemia Tumor Suppressors to RAD51-BRCA1/2
Katharina Schlacher et al.
CANCER CELL (2012)
Polymorphisms in base-excision & nucleotide-excision repair genes & prostate cancer risk in north Indian population
RamaDevi Mittal et al.
INDIAN JOURNAL OF MEDICAL RESEARCH (2012)
The mutational landscape of lethal castration-resistant prostate cancer
Catherine S. Grasso et al.
NATURE (2012)
Inactivation of ATM/ATR DNA Damage Checkpoint Promotes Androgen Induced Chromosomal Instability in Prostate Epithelial Cells
Yung-Tuen Chiu et al.
PLOS ONE (2012)
Double-Strand Break Repair-Independent Role for BRCA2 in Blocking Stalled Replication Fork Degradation by MRE11
Katharina Schlacher et al.
CELL (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Common Gene Rearrangements in Prostate Cancer
Mark A. Rubin et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Base excision repair genes XRCC1 and APEX1 and the risk for prostate cancer
H. Kuasne et al.
MOLECULAR BIOLOGY REPORTS (2011)
Therapeutic Targeting of the DNA Mismatch Repair Pathway
Sarah A. Martin et al.
CLINICAL CANCER RESEARCH (2010)
BRCA1 Loss Preexisting in Small Subpopulations of Prostate Cancer Is Associated with Advanced Disease and Metastatic Spread to Lymph Nodes and Peripheral Blood
Natalia Bednarz et al.
CLINICAL CANCER RESEARCH (2010)
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
Andrew Tutt et al.
LANCET (2010)
The DNA Damage Response: Making It Safe to Play with Knives
Alberto Ciccia et al.
MOLECULAR CELL (2010)
Brca2 and Trp53 Deficiency Cooperate in the Progression of Mouse Prostate Tumourigenesis
Jeffrey C. Francis et al.
PLOS GENETICS (2010)
PARP inhibition: PARP1 and beyond
Michele Rouleau et al.
NATURE REVIEWS CANCER (2010)
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
Francesco Colotta et al.
CARCINOGENESIS (2009)
Tumor Suppressor BRCA1 Is Expressed in Prostate Cancer and Controls Insulin-like Growth Factor I Receptor (IGF-IR) Gene Transcription in an Androgen Receptor-Dependent Manner
Hagit Schayek et al.
CLINICAL CANCER RESEARCH (2009)
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers.
Peter C. Fong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Androgen regulation of the androgen receptor coregulators
Alfonso Urbanucci et al.
BMC CANCER (2008)
Loss of BRCA2 promotes prostate cancer cell invasion through up-regulation of matrix metalloproteinase-9
Loredana Moro et al.
CANCER SCIENCE (2008)
High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs
Sven Rottenberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Selective induction of chemotherapy resistance of mammary tumors in a conditional mouse model for hereditary breast cancer
Sven Rottenberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
A unified view of base excision repair: Lesion-dependent protein complexes regulated by post-translational modification
Karen H. Almeida et al.
DNA REPAIR (2007)
The DNA damage machinery and homologous recombination pathway act consecutively to protect human telomeres
Ramiro E. Verdun et al.
CELL (2006)
The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stability
K. Gudmundsdottir et al.
ONCOGENE (2006)
被撤回的出版物: Cockayne syndrome A and B proteins differentially regulate recruitment of chromatin remodeling and repair factors to stalled RNA polymerase II in vivo (Retracted article. See vol. 81, pg. 5112, 2021)
Maria Fousteri et al.
MOLECULAR CELL (2006)
The multifaceted mismatch-repair system
J Jiricny
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
DNA mismatch repair: Functions and mechanisms
RR Iyer et al.
CHEMICAL REVIEWS (2006)
Centrin 2 stimulates nucleotide excision repair by interacting with xeroderma pigmentosum group C protein
R Nishi et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
J Bartkova et al.
NATURE (2005)
Epigenetic changes in prostate cancer: Implication for diagnosis and treatment
LC Li et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Xrcc4 physically links DNA end processing by polynucleotide kinase to DNA ligation by DNA ligase IV
CA Koch et al.
EMBO JOURNAL (2004)
A biochemically defined system for mammalian nonhomologous DNA end joining
YM Ma et al.
MOLECULAR CELL (2004)
DNA repair gene XRCC1 and XPD polymorphisms and risk of prostate cancer
BA Rybicki et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2004)
Hallmarks of 'BRCAness' in sporadic cancers
N Turner et al.
NATURE REVIEWS CANCER (2004)
An ACF1-ISWI chromatin-remodeling complex is required for DNA replication through heterochromatin
N Collins et al.
NATURE GENETICS (2002)
Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade
Y Iwai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Defining interactions between DNA-PK and ligase IV/XRCC4
HL Hsu et al.
DNA REPAIR (2002)
Hairpin opening and overhang processing by an Artemis/DNA-dependent protein kinase complex in nonhomologous end joining and V(D)J recombination
YM Ma et al.
CELL (2002)
Cancer susceptibility and the functions of BRCA1 and BRCA2
AR Venkitaraman
CELL (2002)
Expression of prostate specific antigen (PSA) is negatively regulated by p53
KV Gurova et al.
ONCOGENE (2002)
ATP-dependent chromatin remodeling activities
K Havas et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2001)
BRCA1 and BRCA2 and the genetics of breast and ovarian cancer
PL Welcsh et al.
HUMAN MOLECULAR GENETICS (2001)
Histone deacetylase inhibitors: Inducers of differentiation or apoptosis of transformed cells
PA Marks et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
The ISWI chromatin-remodeling protein is required for gene expression and the maintenance of higher order chromatin structure in vivo
R Deuring et al.
MOLECULAR CELL (2000)
MLH3: a DNA mismatch repair gene associated with mammalian microsatellite instability
SM Lipkin et al.
NATURE GENETICS (2000)
分享论文
